CD34 + CD38 − and CD34 + HLA-DR − cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation

By Zubair Ac   Kao G   Daley H   Schott D   Freedman A   Ritz J  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 399-407

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical Relevance of CD34⁺ Cell Measurements in PBSC Transplantation

By Watts MJ  

Cytotherapy, Vol. 1, Iss. 4, 1999-01 ,pp. : 348-350

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Genetically modified CD34 + cells do not contribute to the mesenchymal compartment after autologous transplantation in the baboon

By Keyser KA   Morris JC   Kiem H-P  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 345-352

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34⁺⁺ cells in autologous hematopoietic progenitor cell transplantation

By Veeraputhiran Muthu   Katragadda Lakshmikanth   Balamurugan Appathurai   Cottler-Fox Michele  

Cytotherapy, Vol. 13, Iss. 10, 2011-11 ,pp. : 1256-1258

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Peripheral blood and BM CD34 + CD38 − cells show better resistance to cryopreservation than CD34 + CD38 + cells in autologous stem cell transplantation

By Ojeda-uribe M   Sovalat H   Bourderont D   Brunot A   Marr A   Lewandowski H   Chabouté V   Peter P   Henon PH  

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 571-583

Ashgate Publishing Ltd

Access to resources Recommend Favorite